{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:12:54Z","timestamp":1793643174943,"version":"4.5.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.tem.2023.12.003","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T14:19:04Z","timestamp":1703341144000},"page":"347-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["A clinical perspective on ectopic Cushing\u2019s syndrome"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-9492","authenticated-orcid":false,"given":"Oskar","family":"Ragnarsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-9081","authenticated-orcid":false,"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-0981","authenticated-orcid":false,"given":"David J.","family":"Torpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-6987","authenticated-orcid":false,"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2023.12.003_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tem.2023.01.002","article-title":"Corticosteroid-binding globulin (CBG): spatiotemporal distribution of cortisol in sepsis","volume":"34","author":"Lee","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2023.12.003_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cen.14014","article-title":"The incidence of endogenous Cushing's syndrome in the modern era","volume":"91","author":"Wengander","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/jcem-22-7-693","article-title":"Cause of Cushing's syndrome in patients with tumors arising from \"nonendocrine\" tissue","volume":"22","author":"Meador","year":"1962","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archinte.1963.03620280071011","article-title":"Nonpituitary neoplasms and Cushing's syndrome. Ectopic \"adrenocorticotropin\" produced by nonpituitary neoplasms as a cause of Cushing's syndrome","volume":"111","author":"Liddle","year":"1963","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tem.2023.12.003_bb0030","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12020-021-02768-0","article-title":"Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort","volume":"74","author":"Toivanen","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2023.12.003_bb0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0050","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing\u2019s syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0055","article-title":"Is ectopic Cushing's syndrome underdiagnosed in patients with small cell lung cancer?","volume":"9","author":"Piasecka","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.tem.2023.12.003_bb0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11102-018-0894-2","article-title":"Two types of ectopic Cushing syndrome or a continuum? Review","volume":"21","author":"Araujo Castro","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.tem.2023.12.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13030","article-title":"Adrenalectomy in ectopic Cushing's syndrome: a retrospective cohort study from a tertiary care centre","volume":"33","author":"Lase","year":"2021","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0070","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/EJE-19-0877","article-title":"Management of endocrine disease: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion","volume":"182","author":"Young","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0075","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2009-2282","article-title":"Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors","volume":"95","author":"Zemskova","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0080","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1002\/cncr.26029","article-title":"Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience","volume":"117","author":"Ejaz","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.tem.2023.12.003_bb0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12020-016-1127-y","article-title":"Frequency of Cushing's syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center","volume":"55","author":"Falhammar","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2023.12.003_bb0090","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review","volume":"100","author":"Isidori","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0095","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1210\/clinem\/dgaa488","article-title":"Ectopic ACTH- and\/or CRH-producing pheochromocytomas","volume":"106","author":"Elliott","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0100","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad454","article-title":"Ovine CRH stimulation and 8 mg dexamethasone suppression tests in 323 patients with ACTH-dependent Cushing's syndrome","author":"Elenius","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0110","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1210\/clinem\/dgac686","article-title":"Dynamic testing for differential diagnosis of ACTH-dependent Cushing syndrome: a systematic review and meta-analysis","volume":"108","author":"Ceccato","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12020-019-01895-z","article-title":"Novel PET tracers: added value for endocrine disorders","volume":"64","author":"Bergeret","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2023.12.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac073","article-title":"The Mount Sinai clinical pathway for the diagnosis and management of hypercortisolism due to ectopic ACTH syndrome","volume":"6","author":"Alba","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.tem.2023.12.003_bb0125","doi-asserted-by":"crossref","first-page":"e1937","DOI":"10.1210\/clinem\/dgaa982","article-title":"Metastatic pheochromocytomas and abdominal paragangliomas","volume":"106","author":"Granberg","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.51.89","article-title":"Adrenocortical hyperplasia associated with ACTH-dependent Cushing's syndrome: comparison of the size of adrenal glands with clinical and endocrinological data","volume":"51","author":"Imaki","year":"2004","journal-title":"Endocr. J."},{"key":"10.1016\/j.tem.2023.12.003_bb0135","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/cncy.21765","article-title":"Algorithmic approach to neuroendocrine tumors in targeted biopsies: practical applications of immunohistochemical markers","volume":"124","author":"Duan","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.tem.2023.12.003_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12022-020-09645-y","article-title":"Clinical routine application of the second-generation neuroendocrine markers ISL1, INSM1, and secretagogin in neuroendocrine neoplasia: staining outcomes and potential clues for determining tumor origin","volume":"31","author":"Juhlin","year":"2020","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.tem.2023.12.003_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.tem.2023.12.003_bb0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00428-019-02612-x","article-title":"ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature","volume":"475","author":"La Rosa","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.tem.2023.12.003_bb0155","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2011-3355","article-title":"Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years","volume":"97","author":"Neary","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PAS.0000000000000340","article-title":"ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature","volume":"39","author":"Maragliano","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tem.2023.12.003_bb0165","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/curroncol30040312","article-title":"A case of Cushing's syndrome from well-differentiated neuroendocrine tumors of the small bowel and its mesentery","volume":"30","author":"Carlaw","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.tem.2023.12.003_bb0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00428-023-03596-5","article-title":"Renal neuroendocrine tumors: clinical and molecular pathology with an emphasis on frequent association with ectopic Cushing syndrome","volume":"483","author":"Kasajima","year":"2023","journal-title":"Virchows Arch."},{"key":"10.1016\/j.tem.2023.12.003_bb0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/000313480807400714","article-title":"Presentation of a medullary endocrine neoplasia 2A kindred with Cushing's syndrome","volume":"74","author":"Zaydfudim","year":"2008","journal-title":"Am. Surg."},{"key":"10.1016\/j.tem.2023.12.003_bb0180","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68436","article-title":"Single-cell transcriptome analysis identifies a unique tumor cell type producing multiple hormones in ectopic ACTH and CRH secreting pheochromocytoma","volume":"10","author":"Zhang","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.tem.2023.12.003_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00428-022-03484-4","article-title":"Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts","volume":"482","author":"Agaimy","year":"2023","journal-title":"Virchows Arch."},{"key":"10.1016\/j.tem.2023.12.003_bb0190","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1677\/ERC-08-0325","article-title":"Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism","volume":"16","author":"Bi","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.tem.2023.12.003_bb0195","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1210\/clinem\/dgaa507","article-title":"The clinical features and molecular mechanisms of ACTH-secreting pancreatic neuroendocrine tumors","volume":"105","author":"Zhang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0200","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/cancers14040917","article-title":"Pheochromocytomas and abdominal paragangliomas: a practical guidance","volume":"14","author":"Calissendorff","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2023.12.003_bb0205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.amjsurg.2020.08.047","article-title":"Differences in outcomes of bilateral adrenalectomy in patients with ectopic ACTH producing tumor of known and unknown origin","volume":"221","author":"Szabo Yamashita","year":"2021","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.tem.2023.12.003_bb0210","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1530\/EJE-19-0475","article-title":"Commentary on article: adrenal crisis in treated patients with Cushing's syndrome","volume":"181","author":"Torpy","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0215","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5694\/mja2.52140","article-title":"Glucocorticoid-induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning","volume":"219","author":"Torpy","year":"2023","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.tem.2023.12.003_bb0220","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing's disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0225","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12020-018-1675-4","article-title":"Metyrapone treatment in Cushing's syndrome: a real-life study","volume":"62","author":"Ceccato","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2023.12.003_bb0230","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1530\/EJE-22-0506","article-title":"Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes","volume":"187","author":"Fleseriu","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0235","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0091270003255645","article-title":"Gastric function in the elderly: effects on absorption of ketoconazole","volume":"43","author":"Hurwitz","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tem.2023.12.003_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","article-title":"Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome","volume":"35","author":"Verhelst","year":"1991","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/acb.2011.011014","article-title":"Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11beta-hydroxylase inhibitor metyrapone","volume":"48","author":"Monaghan","year":"2011","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.tem.2023.12.003_bb0250","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2147\/DDDT.S315359","article-title":"Clinical utility of osilodrostat in Cushing's disease: review of currently available literature","volume":"17","author":"Perosevic","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.tem.2023.12.003_bb0255","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211058583","article-title":"Pharmacological management of severe Cushing's syndrome: the role of etomidate","volume":"13","author":"Pence","year":"2022","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0260","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0265","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing's syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0270","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0275","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1301428","article-title":"Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma","volume":"369","author":"Baudry","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.12.003_bb0280","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.3390\/curroncol29050282","article-title":"Successful treatment with selpercatinib for ectopic Cushing's syndrome due to medullary thyroid cancer","volume":"29","author":"Ragnarsson","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.tem.2023.12.003_bb0285","first-page":"92","article-title":"Cyclic ectopic Cushing's syndrome and somatostatin analogue treatment","volume":"122","author":"Falhammar","year":"2009","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.tem.2023.12.003_bb0290","first-page":"201","article-title":"Ectopic Cushing's syndrome in light of modern diagnostic techniques and treatment options","volume":"36","author":"Witek","year":"2015","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.tem.2023.12.003_bb0295","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.semnuclmed.2009.10.004","article-title":"Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Kwekkeboom","year":"2010","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.tem.2023.12.003_bb0300","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00259-006-0355-4","article-title":"Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin","volume":"34","author":"van Essen","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tem.2023.12.003_bb0305","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.3390\/cancers15225440","article-title":"Lung carcinoids: a comprehensive review for clinicians","volume":"15","author":"Granberg","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2023.12.003_bb0310","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.12.003_bb0315","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0320","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","article-title":"Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"40","author":"Fallo","year":"2022","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2023.12.003_bb0325","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1210\/jc.2005-0582","article-title":"Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status","volume":"91","author":"Tauchmanova","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0330","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00198-007-0514-x","article-title":"Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome","volume":"19","author":"Futo","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2023.12.003_bb0335","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00268-007-9394-7","article-title":"Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: prospective study","volume":"32","author":"Kawamata","year":"2008","journal-title":"World J. Surg."},{"key":"10.1016\/j.tem.2023.12.003_bb0340","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.1992.tb01437.x","article-title":"Normal bone mineral density following cure of Cushing's syndrome","volume":"36","author":"Manning","year":"1992","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0345","first-page":"2859","article-title":"Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome","volume":"80","author":"Hermus","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0350","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2023.12.003_bb0355","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-16-0809","article-title":"Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study","volume":"176","author":"Davi","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0360","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.24739","article-title":"Characterization of outcomes by surgical management of lung neuroendocrine tumors associated with Cushing syndrome","volume":"4","author":"Seastedt","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2023.12.003_bb0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-18-0212","article-title":"Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up","volume":"179","author":"Osswald","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0370","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4158\/EP15647.OR","article-title":"Clinical presentation and long-term outcome of patients with ectopic acth syndrome due to bronchial carcinoid tumors: a one-center experience","volume":"21","author":"Tsirona","year":"2015","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.tem.2023.12.003_bb0375","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0380","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/cen.14617","article-title":"Medullary thyroid cancer with ectopic Cushing\u2019s syndrome: a multicentre case series","volume":"96","author":"Koehler","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2023.12.003_bb0385","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with cushing disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.12.003_bb0390","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/JTO.0000000000000116","article-title":"Prognostic impact of paraneoplastic cushing's syndrome in small-cell lung cancer","volume":"9","author":"Nagy-Mignotte","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.tem.2023.12.003_bb0395","first-page":"1","article-title":"ALD1613, a novel long-acting monoclonal antibody to control ACTH-driven pharmacology","volume":"158","author":"Feldhaus","year":"2017","journal-title":"Endocrinology"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023002485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023002485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T16:59:06Z","timestamp":1730998746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276023002485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1043276023002485"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2023.12.003","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical perspective on ectopic Cushing\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}